Kathleen M Mullane

Kathleen M Mullane

UNVERIFIED PROFILE

Are you Kathleen M Mullane?   Register this Author

Register author
Kathleen M Mullane

Kathleen M Mullane

Publications by authors named "Kathleen M Mullane"

Are you Kathleen M Mullane?   Register this Author

31Publications

681Reads

-Profile Views

Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in Solid Organ Transplant Recipients: Guidelines from the American Society of Transplantation Community of Practice.

Clin Transplant 2019 Apr 19:e13564. Epub 2019 Apr 19.

Department of Medicine, Washington University School of Medicine, St. Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ctr.13564DOI Listing
April 2019

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2019 Feb 4;25(2):369-381. Epub 2018 Oct 4.

Department of Medicine, University of Washington, Seattle, Washington; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183060
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.09.038DOI Listing
February 2019

Isavuconazole for treatment of rare invasive fungal diseases.

Mycoses 2018 Aug;61(8):518-533

Infectious Disease Unit, Sheba Medical Center, Tel Hashomer, and The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/myc.12778DOI Listing
August 2018

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.

N Engl J Med 2017 12 6;377(25):2433-2444. Epub 2017 Dec 6.

From the Dana-Farber Cancer Institute and Brigham and Women's Hospital (F.M.M.) and Tufts Medical Center and Tufts University School of Medicine (D.R.S.), Boston; Karolinska University Hospital and Karolinska Institutet, Stockholm (P.L.); University of Texas M.D. Anderson Cancer Center, Houston (R.F.C.); Universitaire Ziekenhuizen Leuven, Leuven, Belgium (J.M.); City of Hope National Medical Center, Duarte (S.S.D.), and Stanford University School of Medicine, Palo Alto (J.B.) - both in California; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid (R.F.D.); Juravinski Hospital and Cancer Center, McMaster University, Hamilton, ON, Canada (S.H.); Universitätsklinikum Würzburg, Würzburg, Germany (A.J.U., H.E.); Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Hiroshima (Y. Katayama), and Saitama Medical Center, Jichi Medical University, Saitama (Y. Kanda) - both in Japan; University of Chicago, Chicago (K.M.M.); Fred Hutchinson Cancer Research Center, Seattle (M.B.); Perelman School of Medicine at the University of Pennsylvania, Philadelphia (E.A.B.); and Merck, Kenilworth, NJ (M.J.D., V.L.T., H.W., Y.M., N.A.K., R.Y.L., C.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1706640DOI Listing
December 2017

Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial.

J Antimicrob Chemother 2016 10 17;71(10):2964-71. Epub 2016 Jul 17.

The University of Chicago Department of Medicine, 5841 S. Maryland Avenue, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkw246DOI Listing
October 2016

Herpes zoster and radiation therapy: what radiation oncologists need to know about diagnosing, preventing, and treating herpes zoster.

Pract Radiat Oncol 2014 Jan-Feb;4(1):58-64. Epub 2013 Mar 27.

Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2013.02.004DOI Listing
January 2015

Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation.

N Engl J Med 2014 May;370(19):1781-9

From the University of Texas M.D. Anderson Cancer Center, Houston (R.F.C., R.E.C.); University Medical Center (A.J.U.) and private statistical consultation (H.N.), Mainz, AiCuris, Wuppertal (S.S., M.P.R., K.K., H.P.S., P.L., H.Z., H.R.-S.), Medizinische Klinik und Poliklinik I, Universitatsklinikum Dresden, Dresden (M.B., G.E.), Universitatsklinikum Münster, Münster (C.G.), and Department of Internal Medicine II, Julius-Maximilians-University, Würzburg (H.E.) - all in Germany; University of Iowa, Iowa City (M.S.); University of Chicago Medical Center, Chicago (K.M.M.); and Stanford University Hospital, Stanford, CA (J.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1309533DOI Listing
May 2014

Reply to M.R. Green et al.

J Clin Oncol 2013 Dec 28;31(34):4379. Epub 2013 Oct 28.

University Hospital and Zentrum für Klinische Studien, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.9420DOI Listing
December 2013

Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials.

Am J Nephrol 2013 20;38(1):1-11. Epub 2013 Jun 20.

Department of Medicine, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000351757DOI Listing
October 2013

CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.

N Engl J Med 2013 Sep;369(13):1227-36

Division of Infectious Diseases, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1303688DOI Listing
September 2013

Emerging therapies for Clostridium difficile infection - focus on fidaxomicin.

Infect Drug Resist 2013 28;6:41-53. Epub 2013 Jun 28.

Department of Medicine, Section of Infectious Diseases, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/IDR.S24434DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702225PMC
July 2013

Fidaxomicin: first-in-class macrocyclic antibiotic.

Expert Rev Anti Infect Ther 2011 Jul;9(7):767-77

Department of Medicine, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/eri.11.53DOI Listing
July 2011

Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.

Surg Infect (Larchmt) 2009 Oct;10(5):447-51

Department of Surgery, Section of General Surgery, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
https://www.liebertpub.com/doi/10.1089/sur.2008.049
Publisher Site
http://dx.doi.org/10.1089/sur.2008.049DOI Listing
October 2009

Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.

Thromb Haemost 2004 Sep;92(3):575-82

University of Nebraska Medical Center, Section of Oncology/Hematology, 987680 Nebraka Medical Center, Omaha, Nebraska 68198-7680, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH03-11-0686DOI Listing
September 2004